Our research partners

ADITEC's research partners are mainly based in Europe, but also excellent groups from the US join the project. Scientists from 13 countries and 42 research partners collaborate in the ADITEC project:

 

Austria
• Valneva Austria GmbH (formerly Intercell)
  
• Institute for Biomedical Aging Research / University of Innsbruck
  
• Hookipa Biotech GmbH

Belgium

• GSK Biologicals
  

Denmark
• Statens Serum Institut

France
• Institut Pasteur 
• French Atomic Energy
• Institut de Biologie et Chimie des Protéines (CNRS)
• Medicine in need

Germany
• Max-Planck-Institute for Infection Biology

Iceland
• deCODE Genetics

Ireland
• Sigmoid Pharma

Italy
• Sclavo Vaccines Association
• GlaxoSmithKline Vaccine
• University of Siena
• Fondazione Humanitas per la Ricerca
• Istituto Superiore di Sanità
• ALTA s.r.l.u.
• REITHERA srl
• Microbiotec s.r.l.
• GSK VACCINES INSTITUTE FOR GLOBAL HEALTH SRL
• VisMederi s.r.l.

Norway
• Vaccibody

Sweden
• University of Gothemburg
• Duotol AB
• Abera Bioscience AB
  

Switzerland
• University of Geneva
• Fondazione per l’Istituto di Ricerca in Biomedicina
• World Health Organization
  
  The Netherlands
• Leiden University Medical Center
• Tuberculosis Vaccine Initiative
• Utrecht University
• Erasmus Medical Center
• Crossbeta Biosciences
• Bioneedle Group

United Kingdom

• University of Surrey
• University of Oxford
• Kings College London
• National Institute for Biological Standards and Control / Medicines and Healthcare Products Regulatory Agency (MHRA/NIBSC)
• Imperial College London

United States of America
• Emory University Atlanta
• Infectious Disease Research Institute Seattle
• Seattle Biomedical Research Institute